Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Amortizatization of Intangibles: 2011-2024

Historic Amortizatization of Intangibles for Adma Biologics (ADMA) over the last 11 years, with Dec 2024 value amounting to $951,000.

  • Adma Biologics' Amortizatization of Intangibles fell 32.54% to $170,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $739,000, marking a year-over-year decrease of 48.32%. This contributed to the annual value of $951,000 for FY2024, which is 63.34% down from last year.
  • Adma Biologics' Amortizatization of Intangibles amounted to $951,000 in FY2024, which was down 63.34% from $2.6 million recorded in FY2023.
  • Adma Biologics' 5-year Amortizatization of Intangibles high stood at $2.6 million for FY2023, and its period low was $951,000 during FY2024.
  • In the last 3 years, Adma Biologics' Amortizatization of Intangibles had a median value of $2.4 million in 2022 and averaged $2.0 million.
  • As far as peak fluctuations go, Adma Biologics' Amortizatization of Intangibles grew by 26.62% in 2022, and later tumbled by 63.34% in 2024.
  • Over the past 5 years, Adma Biologics' Amortizatization of Intangibles (Yearly) stood at $1.8 million in 2020, then increased by 6.43% to $1.9 million in 2021, then climbed by 26.62% to $2.4 million in 2022, then rose by 7.99% to $2.6 million in 2023, then crashed by 63.34% to $951,000 in 2024.